-0.000296033155713381 -0.00133214920071053 -0.000740082889283558 -0.00177619893428071 -0.00333037300177611 -0.00251628182356426 -0.00318235642391953 -0.00451450562462985
Thanks for submitting the form.
Stockreport

Gilead Q1 Earnings Preview: Most Gains Wiped Out - Cause For Concern? [Seeking Alpha]

Gilead Sciences, Inc. (GILD)  More Company Research Source: Seeking Alpha
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
Gilead Sciences will report its Q1 2024 earnings on Thursday, April 25. Hence, and considering my last article was published in late 2022, it's time for an update. In this earnings preview, I take a look at the pharmaceutical company's past earnings track record and share what to expect from Gilead's Q1 earnings report. I also take a fresh look at Gilead's drug portfolio, patent cliff, operational qualities and balance sheet. Finally, I give a brief valuation update and share whether I think GILD stock is a good buy ahead of Q1 earnings. Gilead Sciences Overview It's been quite a while since I first covered what I termed the ugly duckling of Big Pharma, Gilead Sciences, Inc. NASDAQ: GILD ). My last article was published Recommended For You Recommended For You About GILD Stock [Read more]

IMPACT SNAPSHOT EVENT TIME: GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Stockreport

Gilead Q1 Earnings Preview: Most Gains Wiped Out - Cause For Concern? [Seeking Alpha]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
Gilead Sciences will report its Q1 2024 earnings on Thursday, April 25. Hence, and considering my last article was published in late 2022, it's time for an update. In this earnings preview, I take a look at the pharmaceutical company's past earnings track record and share what to expect from Gilead's Q1 earnings report. I also take a fresh look at Gilead's drug portfolio, patent cliff, operational qualities and balance sheet. Finally, I give a brief valuation update and share whether I think GILD stock is a good buy ahead of Q1 earnings. Gilead Sciences Overview It's been quite a while since I first covered what I termed the ugly duckling of Big Pharma, Gilead Sciences, Inc. NASDAQ: GILD ). My last article was published Recommended For You Recommended For You About GILD Stock [Read more]

IMPACT SNAPSHOT
EVENT TIME:
GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS